Direct Biologics, Llc
Clinical trials sponsored by Direct Biologics, Llc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could stem cell secretions tame tough Crohn's? new trial aims to find out Results expected Jun 2027 (estimated)
- Stem cell particles aim to heal painful Crohn's fistulas Results expected Jul 2027 (estimated)
-
Could stem cell secretions tame tough Crohn's? new trial aims to find out
Disease control Recruiting nowThis study tests a new treatment called DB-3Q for people with Crohn's disease that hasn't improved with standard therapies. DB-3Q is made from stem cells and may help reduce inflammation in the gut. The trial will enroll 36 adults and focus on safety and how well the treatment wo…
Phase 2 • Sponsor: Direct Biologics, LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Stem cell particles aim to heal painful Crohn's fistulas
Disease control Recruiting nowThis study tests an experimental treatment called DB-3Q, made from stem cell particles, for people with Crohn's disease who have painful tunnels (fistulas) near the anus. About 36 adults will receive either the treatment or a placebo to see if it safely closes the fistulas and im…
Phase 2 • Sponsor: Direct Biologics, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can stem cell vesicles save lives in severe ARDS?
Disease control Recruiting nowThis phase 3 trial tests whether a single intravenous dose of ExoFlo, made from bone marrow stem cell vesicles, can lower the death rate in hospitalized adults with moderate-to-severe ARDS. About 970 participants will receive either ExoFlo or a placebo. The main goal is to see if…
Phase 3 • Sponsor: Direct Biologics, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC